Close Menu

NEW YORK — Fios Genomics will provide bioinformatics, statistics, and computational biology services to Charles River Laboratories International under a partnership announced Thursday. 

Edinburgh, UK-based Fios Genomics will help Charles River, of Wilmington, Massachusetts, with sourcing and analysis of multi-variant datasets to inform drug discovery. These datasets will cover microarrays, next-generation sequencing, proteomics, metabolomics, and epigenetics, plus the associated metadata, the companies said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.